Skip to main content

Table 1 Patient characteristics

From: Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer

Variable

Cancer

(n = 221)

High-risk

(n = 18)

Healthy control

(n = 69)

p-value

Age at surgery (years)

57 (47–66)

45 (36–51)

38 (26–47)

< 0.0001

Racea

   

< 0.0001

 Caucasian

191 (86%)

14 (78%)

37 (54%)

 

 African American

26 (12%)

4 (22%)

27 (40%)

 

 Others

4 (2%)

 

4 (6%)

 

TNM stagea

 0

3 (1.5%)

   

 1

124 (63%)

   

 2

44 (22%)

   

 3

27 (13.5%)

   

Gradea

 1

24 (11%)

   

 2

86 (40%)

   

 3

107 (49%)

   

Histology

 IDC

164 (74%)

   

 ILC

27 (12%)

   

 IDC + ILC

12 (6%)

   

 Others

18 (8%)

   

ER+a

164 (82%)

   

PR+a

143 (72%)

   

HER2+a

15 (8%)

   

TNBCa

30 (15%)

   

LVIa

90 (43%)

   

Node positivea

109 (52%)

   
  1. Data are presented as number of patients (%) or median (interquartile range)
  2. aMissing data: age (n = 1), race (n = 1), stage (n = 23), grade (n = 4), ER (n = 21), PR (n = 22), HER2 (n = 37), TNBC (n = 23), LVI (n = 14), and node-positive status (n = 10). Percentages are calculated from the total number of patients with known values
  3. IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor 2; TNBC, triple-negative breast cancer; LVI, lymphovascular invasion
Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us